The landscape of dementia diagnosis has progressed considerably with the advent of sophisticated biomarkers, which includes amyloid PET scans, tau imaging, and blood-dependent checks that can detect Alzheimer's pathology many years ahead of signs or symptoms arise. While these technological advances signify impressive progress in knowledge neurodeg